Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Guangzhou Bio-gene Technology Co., Ltd, situated in Guangzhou city, Guangdong Province, China, specializes in pioneering cell therapies for blood malignancies and solid tumors. Established in 2015, it operates as a wholly-owned subsidiary of HEDY Group Co., LTD. Over the past five years, Guangzhou Bio-gene has developed a robust product pipeline featuring various chimeric antigen receptor T cell products, including anti-CD19 C...
Guangzhou Bio-gene Technology Co., Ltd, situated in Guangzhou city, Guangdong Province, China, specializes in pioneering cell therapies for blood malignancies and solid tumors. Established in 2015, it operates as a wholly-owned subsidiary of HEDY Group Co., LTD. Over the past five years, Guangzhou Bio-gene has developed a robust product pipeline featuring various chimeric antigen receptor T cell products, including anti-CD19 CAR-T, CD19-CD22 bispecific CAR-T, novel target CAR-T, and universal CAR-T.

List your booth number for exhibitions, ask us

Contact Guangzhou Bio-gene Technology and get a quotation

Guangzhou Bio-gene Technology is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find EXP EXOSOME bulk with DMF offered by Guangzhou Bio-gene Technology